• 1
    Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327336.
  • 2
    Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161195.
  • 3
    Sasaguri Y, Murahashi N, Sugama K, Kato S, Hiraoka K, Satoh T, Isomoto H. et al. Developmental-related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Lab Invest 1994; 71: 261269.
  • 4
    Reponen P, Sahlberg G, Munaut C, Thesleff I, Tryggvason K. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Biol Chem 1994; 124: 10911102.
  • 5
    Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, Bayliss MT. et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1993; 66: 680690.
  • 6
    Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H. et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 1995; 72: 311322.
  • 7
    Levy AT, Cioce V, Sobel ME, Garbisa WF, Liotta LA, Stetler-Stevenson WG. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991; 51: 439444.
  • 8
    Monteagudo C, Merino MJ, San-Juan J, Liotta LA, Stetler-Stevenson WG. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol 1990; 136: 585592.
  • 9
    Campo E, Merino MJ, Tavassoli FA, Charonis AS, Stetler-Stevenson WG, Liotta LA. Evaluation of basement membrane components and 72 kDa type IV collagenase in serous tumors of the ovary. Am J Surg Pathol 1992; 16: 500507.
  • 10
    Satoh K, Ohtani H, Shimosegawa T, Koizumi M, Sawai T, Toyota T. Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas. Gastroenterology 1994; 107: 14881495.
  • 11
    Okada Y, Harris ED, Nagase H. The precursor of a metalloendo-peptidase from human rheumatoid synovial fibroblasts. Biochem J 1988; 254: 731741.
  • 12
    Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases: an application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990; 127: 103108.
  • 13
    Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled (PAP) procedures. J Histochem Cytochem 1981; 29: 557580.
  • 14
    Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, Longcroft JK. et al. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNA in colorectal neoplasia. Am J Pathol 1992; 141: 389396.
  • 15
    Soini Y, Paakko P, Autio-Harmainen H. Genes of laminin B1 chain, alphal (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas. Am J Pathol 1993; 142: 16221630.
  • 16
    Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K, Tryggvason K. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancer by in situ hybridization. Cancer Res 1992; 52: 13361341.
  • 17
    Koivunen E, Huhtala ML, Stenman UH. Human ovarian tumor-associated trypsin. J Biol Chem 1989; 264: 1409514099.
  • 18
    Sloane BF. Cathepsin B and cystains: evidence for a role in cancer progression. Semin Cancer Biol 1990; 1: 137152.
  • 19
    Eeckhout Y, Yaes G. Further studies on the activation of procollagenases, the latent precursor of bone cartilage: effect of lysosomal cathepsin B, plasmin and kallikrein and spontaneous activation. Biochem J 1977; 166: 2131.
  • 20
    Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K. et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor and enzymatic properties. J Biol Chem 1992; 267: 2171221719.
  • 21
    Terada T, Ohta T, Minato H. NakanumaY. Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas. Hum Pathol 1995; 26: 746752.